<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04140825</url>
  </required_header>
  <id_info>
    <org_study_id>1/17 ADU</org_study_id>
    <nct_id>NCT04140825</nct_id>
  </id_info>
  <brief_title>Within-Breath Total Respiratory Input Impedance in Healthy Adult Subjects</brief_title>
  <official_title>Within-Breath Total Respiratory Input Impedance in Healthy Adult Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Restech Srl</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MGC Diagnostics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Restech Srl</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of lung function requires the evaluation of pulmonary function by spirometry.
      However, some patients (e.g. children, elderly, or diseased individuals) may have difficulty
      performing the related forced maximal respiratory maneuver correctly. Forced oscillation
      technique (FOT) is increasingly being used in clinical settings to evaluate lung function
      noninvasively by measuring the mechanical input impedance of the respiratory system. FOT
      measures lung impedance during tidal breathing, requiring minimal patient cooperation.
      Recently a new methodology (within breath analysis) has emerged to evaluate changes that
      occur in the impedance during the breathing activity. The within-breath calculation of
      impedance allows separating the contribution of inspiration and expiration to the measured
      parameters.

      The purpose of this study is to establish reference ranges for within breath FOT parameters
      and their short term variability.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose and rationale Assessment of lung function requires the evaluation of pulmonary
      function by spirometry. However, some patients (e.g. children, elderly, or diseased
      individuals) may have difficulty performing the related forced maximal respiratory maneuver
      correctly. Forced oscillation technique (FOT) is increasingly being used in clinical settings
      to evaluate lung function noninvasively by measuring the mechanical input impedance of the
      respiratory system. FOT measures lung impedance during tidal breathing, requiring minimal
      patient cooperation. Recently a new methodology (within breath analysis) has emerged to
      evaluate changes that occur in the impedance during the breathing activity. The within-breath
      calculation of impedance allows separating the contribution of inspiration and expiration to
      the measured parameters.

      The purpose of this study is to establish reference ranges for within breath FOT parameters
      and their short term variability.

      Objectives Primary: To derive equations to predict normal values and normality ranges for
      within-breath respiratory system resistance, reactance and related parameters at the selected
      stimulating waveform and to measure the short term variability of such parameters.

      Secondary: To demonstrate the equivalence of the results of a single multiple-breath test to
      results obtained as an average of 3 consecutive repeated tests.

      Study design This will be a prospective multi-center trial of healthy subjects. After signing
      the Informed Consent, an interview and physical examination will be performed. The examiner
      will confirm that subjects are able to perform acceptable and repeatable spirometry. FOT
      measurements will be performed, followed by standard spirometry measurements.

      Study Duration This is a single visit study. Subject participation will be completed in 1
      hour and 15 min. Enrollment of all subjects is expected to take 23 weeks (6 months).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 18, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between respiratory impedance parameters and the following variables: age, height, weight, sex, abdominal circumference and phenotype, breathing pattern parameters.</measure>
    <time_frame>1 day</time_frame>
    <description>The equation resulting from the multivariate regression analysis between impedance parameters assessed during the test and anthropometric measurements of age, height, weight, sex, abdominal circumference and phenotype, breathing pattern parameters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Noninferiority of one FOT test vs. the average of three consecutive tests</measure>
    <time_frame>1 day</time_frame>
    <description>Noninferiority hypothesis of the results of a single test with multiple breaths free from artifacts compared to those obtained in the same session as an average or 3 consecutive repeated tests</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">326</enrollment>
  <condition>Respiratory Disease</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Subjects&gt;=18 years old will measure as a minimum FOT and spirometry.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Resmon PRO FULL</intervention_name>
    <description>Measurement of lung impedance by the Forced Oscillation Technique</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The following group will be considered:

        Adults (&gt;= 18 years old)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects ≥ 18 years of age.

          -  Signature of the written informed consent

        Exclusion Criteria:

        Subjects will be excluded if they meet at least one of the following conditions:

          -  Abnormal spirometry defined as FEV1, FEV1/VC and VC below the LLN as established by
             the Global Lung function (GLI) 2012 reference equations.

          -  Smokers or ex-smokers

          -  BMI &gt;30 kg/cm2

          -  History of respiratory symptoms using the ECRHS II screening questionnaire
             (www.ecrhs.org)

               -  Wheezing

               -  Cough

               -  Phlegm production

               -  Dyspnea

               -  Feeling of chest tightness

               -  Night awakening due to a cough attack

          -  Have a history of pulmonary or cardiac disease

          -  Had a recent (e.g., in the last 4 weeks) respiratory tract infection

          -  Have a neurological or neuromuscular disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonello Fuso, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catholic University of the Sacred Heart</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Kaminsky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Vermont Medical Center Inc</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janos Porszasz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Biomedical Research Institute at Harbor- UCLA Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Felip Burgos Rincón, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínic de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabiano Di Marco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale Papa Giovanni XXIII</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alessandro Gobbi</last_name>
    <phone>+390236593690</phone>
    <email>a.gobbi@restech.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pasquale Pompilio</last_name>
    <phone>+390236593690</phone>
    <email>p.pompilio@restech.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Biomedical Research Institute at Harbor- UCLA Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janos Porszasz, MD</last_name>
      <email>porszasz@ucla.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Vermont Medical Center Inc.</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Alan Kaminsky, MD</last_name>
      <email>david.kaminsky@med.uvm.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Catholic University of the Sacred Heart</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <zip>00100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leonello Fuso, MD</last_name>
      <email>leonello.fuso@policlinicogemelli.it</email>
    </contact>
    <contact_backup>
      <last_name>Chiara Contu, MD</last_name>
      <phone>3487398380</phone>
      <email>chiara.contu@policlinicogemelli.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ospedale Papa Giovanni XXIII</name>
      <address>
        <city>Bergamo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabiano Di Marco</last_name>
    </contact>
    <investigator>
      <last_name>Fabiano Di Marco</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gianluca Imeri</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Felipe Burgos Ricon, MD</last_name>
      <email>FBURGOS@clinic.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>DUBOIS AB, BRODY AW, LEWIS DH, BURGESS BF Jr. Oscillation mechanics of lungs and chest in man. J Appl Physiol. 1956 May;8(6):587-94.</citation>
    <PMID>13331841</PMID>
  </reference>
  <reference>
    <citation>Peslin R, Ying Y, Gallina C, Duvivier C. Within-breath variations of forced oscillation resistance in healthy subjects. Eur Respir J. 1992 Jan;5(1):86-92.</citation>
    <PMID>1577156</PMID>
  </reference>
  <reference>
    <citation>Horowitz JG, Siegel SD, Primiano FP Jr, Chester EH. Computation of respiratory impedance from forced sinusoidal oscillations during breathing. Comput Biomed Res. 1983 Dec;16(6):499-521.</citation>
    <PMID>6653086</PMID>
  </reference>
  <reference>
    <citation>Dellacà RL, Santus P, Aliverti A, Stevenson N, Centanni S, Macklem PT, Pedotti A, Calverley PM. Detection of expiratory flow limitation in COPD using the forced oscillation technique. Eur Respir J. 2004 Feb;23(2):232-40.</citation>
    <PMID>14979497</PMID>
  </reference>
  <reference>
    <citation>Dellacà RL, Pompilio PP, Walker PP, Duffy N, Pedotti A, Calverley PM. Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD. Eur Respir J. 2009 Jun;33(6):1329-37. doi: 10.1183/09031936.00139608. Epub 2009 Jan 22.</citation>
    <PMID>19164347</PMID>
  </reference>
  <reference>
    <citation>Pasker HG, Schepers R, Clément J, Van de Woestijne KP. Total respiratory impedance measured by means of the forced oscillation technique in subjects with and without respiratory complaints. Eur Respir J. 1996 Jan;9(1):131-9.</citation>
    <PMID>8834346</PMID>
  </reference>
  <reference>
    <citation>Brown NJ, Xuan W, Salome CM, Berend N, Hunter ML, Musk AW, James AL, King GG. Reference equations for respiratory system resistance and reactance in adults. Respir Physiol Neurobiol. 2010 Jul 31;172(3):162-8. doi: 10.1016/j.resp.2010.05.013. Epub 2010 May 15.</citation>
    <PMID>20478414</PMID>
  </reference>
  <reference>
    <citation>Aarli BB, Eagan TM, Ellingsen I, Bakke PS, Hardie JA. Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly. Clin Respir J. 2013 Jul;7(3):245-52. doi: 10.1111/j.1752-699X.2012.00312.x. Epub 2012 Aug 20.</citation>
    <PMID>22822726</PMID>
  </reference>
  <reference>
    <citation>Oostveen E, MacLeod D, Lorino H, Farré R, Hantos Z, Desager K, Marchal F; ERS Task Force on Respiratory Impedance Measurements. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003 Dec;22(6):1026-41. Review.</citation>
    <PMID>14680096</PMID>
  </reference>
  <reference>
    <citation>Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J; ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012 Dec;40(6):1324-43. doi: 10.1183/09031936.00080312. Epub 2012 Jun 27.</citation>
    <PMID>22743675</PMID>
  </reference>
  <reference>
    <citation>Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38.</citation>
    <PMID>16055882</PMID>
  </reference>
  <reference>
    <citation>Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G. Standardisation of the measurement of lung volumes. Eur Respir J. 2005 Sep;26(3):511-22. Review.</citation>
    <PMID>16135736</PMID>
  </reference>
  <reference>
    <citation>Calogero C, Simpson SJ, Lombardi E, Parri N, Cuomo B, Palumbo M, de Martino M, Shackleton C, Verheggen M, Gavidia T, Franklin PJ, Kusel MM, Park J, Sly PD, Hall GL. Respiratory impedance and bronchodilator responsiveness in healthy children aged 2-13 years. Pediatr Pulmonol. 2013 Jul;48(7):707-15. doi: 10.1002/ppul.22699. Epub 2012 Nov 20.</citation>
    <PMID>23169525</PMID>
  </reference>
  <reference>
    <citation>Ducharme FM, Davis GM, Ducharme GR. Pediatric reference values for respiratory resistance measured by forced oscillation. Chest. 1998 May;113(5):1322-8.</citation>
    <PMID>9596314</PMID>
  </reference>
  <reference>
    <citation>Oostveen E, Boda K, van der Grinten CP, James AL, Young S, Nieland H, Hantos Z. Respiratory impedance in healthy subjects: baseline values and bronchodilator response. Eur Respir J. 2013 Dec;42(6):1513-23. doi: 10.1183/09031936.00126212. Epub 2013 Apr 18.</citation>
    <PMID>23598954</PMID>
  </reference>
  <reference>
    <citation>Knofczynski, G. T. &amp; Mundfrom, D. Sample Sizes When Using Multiple Linear Regression for Prediction. Educ. Psychol. Meas. 68, 431-442 (2007).</citation>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>June 27, 2019</study_first_submitted>
  <study_first_submitted_qc>October 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2019</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

